Our initiative aimed to produce recommendations on post-randomised controlled trial (RCT) trial extension studies (TES) reporting using European League Against Rheumatism (EULAR) standard operating procedures in order to achieve more meaningful output and standardisation of reports.
Buch, M., Silva Fernandez, L., Carmona, L., Aletaha, D., Christensen, R., Combe, B., Emery, P., Ferraccioli, G., Guillemin, F., Kvien, T., Landewe, R., Pavelka, K., Saag, K., Smolen, J., Symmons, D., Van Der Heijde, D., Welling, J., Wells, G., Westhovens, R., Zink, A., Boers, M., Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology, <<ANNALS OF THE RHEUMATIC DISEASES>>, 2015; 74 (6): 963-969. [doi:10.1136/annrheumdis-2013-204948] [http://hdl.handle.net/10807/71519]
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
Ferraccioli, Gianfranco;
2015
Abstract
Our initiative aimed to produce recommendations on post-randomised controlled trial (RCT) trial extension studies (TES) reporting using European League Against Rheumatism (EULAR) standard operating procedures in order to achieve more meaningful output and standardisation of reports.
| File | Dimensione | Formato | |
|---|---|---|---|
|
963.full.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
5.78 MB
Formato
Adobe PDF
|
5.78 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
